Indisulam was previously identified as an aryl sulfonamide anti-cancer drug to dysregulate DCAF15 binding partners and showed strong specificity to DCAF15 and similar functional effect compared with DCAF15 knockout.52 Here, DCAF15 is linked to cancer.